Labcorp Holdings Inc N6B
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Diagnostic-Testing Stocks Slide After Proposed Cuts to Medicare Payments for Lab Services
-
FDA Approves Alzheimer's Blood Test Developed by Roche and Eli Lilly
-
The latest Oura and Fitbit wearables are smarter and sleeker than ever - but do they keep you healthy?
-
'Dr. Google' is done. AI chatbots like ChatGPT will change how we search for health information.
-
These charts show the stock market giving investors a lot to like - for now - as the S&P 500 nears 7,000
-
Labcorp to Launch Alzheimer's Blood Test in Primary-Care Settings
Trading Information
- Previous Close Price
- €276.00
- Day Range
- €276.00–276.00
- 52-Week Range
- —–290.00
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 81.10M
- Market Cap
- €22.38B
- Volume/Avg
- — / 2
Key Statistics
- Price/Earnings (Normalized)
- 18.41
- Price/Sales
- 1.86
- Dividend Yield (Trailing)
- 0.90%
- Dividend Yield (Forward)
- 0.90%
- Dividend Payment Schedule
- Mar, Jun, Sep, Dec
- Total Yield
- 3.56%
Company Profile
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Mid Core
- Total Number of Employees
- 71,000
- Website
- https://www.labcorp.com
Competitors
Valuation
|
Metric
|
N6B
|
DGX
|
SHL
|
|---|---|---|---|
Price/Earnings (Normalized) | 18.41 | 21.71 | 14.37 |
Price/Book Value | 2.96 | 3.38 | 1.11 |
Price/Sales | 1.86 | 2.25 | 0.85 |
Price/Cash Flow | 11.50 | 13.39 | 6.56 |
Price/Earnings
N6B
DGX
SHL
Financial Strength
|
Metric
|
N6B
|
DGX
|
SHL
|
|---|---|---|---|
Quick Ratio | 1.25 | 1.28 | 0.84 |
Current Ratio | 1.80 | 1.59 | 0.99 |
Interest Coverage | 6.43 | 6.17 | 4.98 |
Quick Ratio
N6B
DGX
SHL
Profitability
|
Metric
|
N6B
|
DGX
|
SHL
|
|---|---|---|---|
Return on Assets (Normalized) | 6.57% | 7.32% | 3.74% |
Return on Equity (Normalized) | 14.08% | 16.42% | 7.39% |
Return on Invested Capital (Normalized) | 9.11% | 10.01% | 5.35% |
Return on Assets
N6B
DGX
SHL
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|%&W!<>Lc | LOCK|Sf# | $243B | |||
| Danaher Corp
DHR
| LOCK|Cb<LPd%> | LOCK|Lt | $155B | |||
| Agilent Technologies Inc
A
| LOCK|CWl&<Q>! | LOCK|wDX | $48B | |||
| IQVIA Holdings Inc
IQV
| LOCK|wp<jx#g | LOCK|>x?@T | $43B | |||
| Waters Corp
WAT
| LOCK|$js%F%N | LOCK|^>y | $43B | |||
| Illumina Inc
ILMN
| LOCK|T^q%^T | LOCK|>wk^T | $42B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|tj>ck&$% | LOCK|>m | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|%NbWpZ$ | LOCK|Qb%s | $31B | |||
| Quest Diagnostics Inc
DGX
| LOCK|GdWZ%x | LOCK|g&b> | $25B | |||
| Labcorp Holdings Inc
LH
| LOCK|pZDjX<tT | LOCK|>WR# | $25B |
United States